BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11727328)

  • 21. [Chemoinformatics and virtual screening of molecules for therapeutic use].
    Vayer P; Arrault A; Lesur B; Bertrand M; Walther B
    Med Sci (Paris); 2009 Oct; 25(10):871-7. PubMed ID: 19849994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel hierarchical classification and visualization method for multiobjective optimization of drug properties: application to structure-activity relationship analysis of cytochrome P450 metabolism.
    Yamashita F; Hara H; Ito T; Hashida M
    J Chem Inf Model; 2008 Feb; 48(2):364-9. PubMed ID: 18211048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoinformatics and library design.
    Zhou JZ
    Methods Mol Biol; 2011; 685():27-52. PubMed ID: 20981517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mining chemical and biological information from the drug literature.
    Banville DL
    Curr Opin Drug Discov Devel; 2009 May; 12(3):376-87. PubMed ID: 19396739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoinformatics and chemical genomics: potential utility of in silico methods.
    Valerio LG; Choudhuri S
    J Appl Toxicol; 2012 Nov; 32(11):880-9. PubMed ID: 22886396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mining chemical structural information from the drug literature.
    Banville DL
    Drug Discov Today; 2006 Jan; 11(1-2):35-42. PubMed ID: 16478689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA toxicity databases and real-time data entry.
    Arvidson KB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):17-9. PubMed ID: 18656494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.
    Camacho R; Pereira M; Costa VS; Fonseca NA; Adriano C; Simões CJ; Brito RM
    J Integr Bioinform; 2011 Sep; 8(3):182. PubMed ID: 21926445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical correction for fingerprint similarity measures to improve chemical retrieval.
    Swamidass SJ; Baldi P
    J Chem Inf Model; 2007; 47(3):952-64. PubMed ID: 17444629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data mining and clinical data repositories: Insights from a 667,000 patient data set.
    Mullins IM; Siadaty MS; Lyman J; Scully K; Garrett CT; Miller WG; Muller R; Robson B; Apte C; Weiss S; Rigoutsos I; Platt D; Cohen S; Knaus WA
    Comput Biol Med; 2006 Dec; 36(12):1351-77. PubMed ID: 16375883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding multiactivity substructures by mining databases of drug-like compounds.
    Sheridan RP
    J Chem Inf Comput Sci; 2003; 43(3):1037-50. PubMed ID: 12767163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A data mining method to facilitate SAR transfer.
    Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in chemoinformatics.
    Agrafiotis DK; Bandyopadhyay D; Wegner JK; Vlijmen Hv
    J Chem Inf Model; 2007; 47(4):1279-93. PubMed ID: 17511441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A database for tracking toxicogenomic samples and procedures.
    Bao W; Schmid JE; Goetz AK; Ren H; Dix DJ
    Reprod Toxicol; 2005; 19(3):411-9. PubMed ID: 15686874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.